Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 5, 2022 (Week 09)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 64 392 1,956 1,287 3 13 48 25
New England - 17 27 57 - 1 - -
Connecticut - 6 3 17 - 0 - -
Maine - 7 12 9 - 0 - -
Massachusetts - 9 - 19 - 0 - -
New Hampshire - 4 5 6 - 1 - -
Rhode Island - 2 4 3 - 1 - -
Vermont - 3 3 3 - 0 - -
Middle Atlantic 25 82 338 198 - 6 14 9
New Jersey 2 12 37 45 - 3 2 9
New York (excluding New York City) 12 44 122 45 - 3 6 -
New York City 7 22 91 57 - 6 - -
Pennsylvania 4 18 88 51 - 2 6 -
East North Central 4 86 377 176 1 4 17 2
Illinois N NC N N N NC N N
Indiana - 20 55 51 - 1 1 -
Michigan 1 18 67 40 1 2 3 1
Ohio - 41 193 82 - 4 13 1
Wisconsin 3 19 62 3 - 0 - -
West North Central 5 27 150 61 - 4 2 4
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 4 22 106 44 - 2 2 4
Nebraska - 7 19 6 - 0 - -
North Dakota - 3 7 2 - 0 - -
South Dakota 1 7 18 9 - 3 - -
South Atlantic 5 63 226 230 2 5 6 3
Delaware 1 5 13 7 - 0 - -
District of Columbia - 2 3 3 - 0 - -
Florida 4 26 102 70 2 3 5 3
Georgia - 17 20 82 - 0 - -
Maryland - 11 - 34 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 25 88 - - 3 1 -
Virginia - 1 - 1 - 0 - -
West Virginia - 13 - 33 - 0 - -
East South Central 3 43 176 149 - 2 1 1
Alabama - 18 52 41 - 1 1 -
Kentucky - 8 26 15 - 2 - 1
Mississippi 3 8 31 24 - 0 - -
Tennessee - 26 67 69 - 0 - -
West South Central - 61 127 127 - 3 1 4
Arkansas - 10 36 13 - 0 - -
Louisiana - 29 13 60 - 1 - -
Oklahoma N NC N N N NC N N
Texas - 51 78 54 - 3 1 4
Mountain 22 91 507 267 - 2 6 2
Arizona 17 44 215 121 - 1 2 1
Colorado - 28 135 50 - 0 - -
Idaho N NC N N N NC N N
Montana - 5 6 9 - 1 - -
Nevada - 10 49 37 - 1 - -
New Mexico - 14 63 29 - 0 - -
Utah 5 12 39 16 - 1 4 1
Wyoming - 3 - 5 - 0 - -
Pacific - 12 28 22 - 2 1 -
Alaska - 11 26 18 - 2 1 -
California N NC N N N NC N N
Hawaii - 3 2 4 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 64 392 1,956 1,288 3 13 48 25
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.